Geranylgeranylacetone selectively binds to the HSP70 of Helicobacter pylori and alters its coccoid morphology

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Grave, Ewa ^a   Yokota, Shin Ichi ^b   Yamamoto, Soh ^b   Tamura, Arisa ^a   Ohtaki Mizoguchi, Takako ^a   Yokota, Kenji ^c   Oguma, Keiji ^d   Fujiwara, Kazuhiko ^a   Ogawa, Nobuaki ^a   Okamoto, Tomoya ^a   Otaka, Michiro ^e   Itoh, Hideaki ^a  

^a AKITA UNIVERSITY   (Japan)

^b SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c OKAYAMA UNIVERSITY   (Japan)

^d OKAYAMA UNIVERSITY   (Japan)

^e JUNTENDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; DITERPENE; HEAT SHOCK PROTEIN 70; PROTEIN BINDING; RECOMBINANT PROTEIN; TEPRENONE;

CHEMISTRY; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; HELICOBACTER PYLORI; HUMAN; METABOLISM; PROTEIN CONFORMATION; SURFACE PLASMON RESONANCE; TUMOR CELL LINE;

BACTERIAL PROTEINS; CELL LINE, TUMOR; DITERPENES; HELICOBACTER PYLORI; HSP70 HEAT-SHOCK PROTEINS; HUMANS; PROTEIN BINDING; PROTEIN CONFORMATION; RECOMBINANT PROTEINS; SURFACE PLASMON RESONANCE;

EID: 84941096182     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep13738     Document Type: Article

References (41)

1. Walker, M. M. & Crabtree, J. E. Helicobacter pylori infection and the pathogenesis of duodenal ulceration. Ann. N. Y. Acad. Sci. 859, 96-111 (1998).
2. Israel, D. A. & Peek, R. M. Jr. The role of persistence in Helicobacter pylori pathogenesis. Curr. Opin. Gastroenterol. 22, 3-7 (2006).
3. Lamb, A. & Chen, L. F. Role of the Helicobacter pylori-induced inflammatory response in the development of gastric cancer. J. Cell. Biochem. 114, 491-7 (2013).
4. Murakami, K. et al. Multi-center randomized controlled study to establish the standard third-line regimen for Helicobacter pylori eradication in Japan. J Gastroenterol. 48, 1128-35 (2013).
5. Chan, W. Y. et al. Coccoid forms of Helicobacter pylori in the human stomach. Am. J. Clin. Pathol. 102, 503-507 (1994).
6. Noach, L. et al. Electron microscopic study of association between Helicobacter pylori and gastric and duodenal mucosa. J. Clin. Pathol. 47, 699-704 (1994).
7. Saita, H. & Murakami, M. Effect of teprenone on gastric mucosal injury induced by Helicobacter pylori in rats. Arzneimittelforschung. 50, 1110-4 (2000).
8. Tatsuta, M. et al. Geranylgeranylacetone attenuates suppression by Helicobacter pylori extract of human umbilical vein epithelial cell growth. Hepatogastroenterology. 51, 1558-60 (2004).
9. Miyake, K. et al. Teprenone, but not H2-receptor blocker or sucralfate, suppresses corpus Helicobacter pylori colonization and gastritis in humans: teprenone inhibition of H. pylori-induced interleukin-8 in MKN28 gastric epithelial cell lines. Helicobacter. 9, 130-7 (2004).
10. Yoshimura, N. et al. Suppression of Helicobacter pylori-induced interleukin-8 production in gastric cancer cell lines by an anti-ulcer drug, geranylgeranylacetone. J. Gastroenterol. Hepatol. 17, 1153-60 (2002).
11. Hirakawa, T. et al. Geranylgeranylacetone induces heat shock proteins in cultured guinea pig gastric mucosal cells and rat gastric mucosa. Gastroenterology. 11, 345-57 (1996).
12. Mikuriya, T. et al. Geranylgeranylacetone, a heat shock protein inducer, prevents acoustic injury in the guinea pig. Brain Res. 1065, 107-14 (2005).
13. Ooie, T. et al. Single oral of geranylgeranylacetone induces heat shock protein 72 and renders protection against ischemia/reperfusion injury in rat heart. Circulation. 104, 1837-43 (2001).
14. Oda, H. et al. Geranylgeranylacetone suppresses inflammatory responses and improves survival after massive hepatectomy in rats. J. Gastrointest. Surg. 6, 464-72 (2002).
15. Uchida, S. et al. Geranylgeranylacetone, a noninvasive heat shock protein inducer, induces protein kinase C and leads to neuroprotection against cerebral infarction in rats. Neurosci. Lett. 396, 220-4 (2006).
16. Ohkawara, T. et al. Protective effect of geranylgeranylacetone on trinitrobenzene sulfonic acid-induced colitis in mice. Int. J. Mol. Med. 17, 229-34 (2006).
17. Freeman, B. C. & Morimoto R. I. The human cytosolic molecular chaperones hsp90, hsp70 (hsc70) and hdj-1 have distinct roles in recognition of a non-native protein and protein refolding. EMBO J. 15, 2969-79 (1996).
18. Chappell, T. G. et al. The ATPase core of a clathrin uncoating protein. J. Biol. Chem. 262, 746-51 (1987).
19. Flaherty, K. M. et al. Three-dimensional structure of the ATPase fragment of a 70K heat-shock cognate protein. Nature. 346, 623-8 (1990).
20. Wang, T.-F. et al. Identification of the peptide binding domain of hsc70. 18-Kilodalton fragment located immediately after ATPase domain is sufficient for high affinity binding. J. Biol. Chem. 268, 26049-26051 (1993).
21. Morghauser, R. C. et al. The peptide-binding domain of the chaperone protein Hsc70 has an unusual secondary structure topology Biochemistry 34, 6261-6266 (1995).
22. Schmid, D. et al. Kinetics of molecular chaperone action. Science 263, 971-973 (1994).
23. Greene, L. E. et al. Effect of nucleotide on the binding of peptides to 70-kDa heat shock protein J. Biol. Chem. 270, 2967-2973 (1995).
24. Otaka, M. et al. The induction mechanism of the molecular chaperone HSP70 in the gastric mucosa by Geranylgeranylacetone (HSP-inducer). Biochem. Biophys. Res. Commun. 353, 399-404 (2007).
25. Ishii, E. Antibacterial activity of teprenone, a non water-soluble antiulcer agent, against Helicobacter pylori. Zentralbl. Bakteriol. 280, 239-43 (1993).
26. Lee, K. E. et al. Helicobacter pylori and interleukin-8 in gastric cancer. World J Gastroenterol. 19, 8192-202 (2013).
27. Yanaka, A. et al. Geranylgeranylacetone protects the human gastric mucosa from diclofenac-induced injury via induction of heat shock protein 70. Digestion 75, 148-155 (2007).
28. DeLoney, C. R. & Schiller, N. L. Competition of various β-lactam antibiotics for the major penicillin-binding proteins of Helicobacter pylori: antibacterial activity and effects on bacterial morphology. Antimicrob. Agents. Chemother. 43, 2702-9 (1999).
29. Berry, V. et al. Bactericidal and morphological effects of amoxicillin on Helicobacter pylori. Antimicrob. Agents. Chemother. 39, 1859-61 (1995).
30. Sorberg, M. et al. Risk of development of in vitro resistance to amoxicillin, clarithromycin, and metronidazole in Helicobacter pylori. Antimicrob. Agents. Chemother. 42, 1222-8 (1998).
31. Figura, N. et al. Factors modulating the outcome of treatment for the eradication of Helicobacter pylori infection. New Microbiol. 35, 335-40 (2012).
32. Brenciaglia, M. I. et al. Helicobacter pylori: cultivability and antibiotic susceptibility of coccoid forms. Int. J. Antimicrob. Agents. 13, 237-41 (2000).
33. Gonzalez-Valencia, G. et al. Susceptibility of Helicobacter pylori to the bactericidal activity of human serum. Helicobacter. 1, 28-33 (1996).
34. Maeda, S. et al. Distinct mechanism of Helicobacter pylori-mediated NF-κB activation between gastric cancer cells and monocytic cells. J. Biol. Chem. 276, 44856-64 (2001).
35. Shibata, W. et al. NF-κB and ERK-signaling pathways contribute to the gene expression induced by cag PAI-positive-Helicobacter pylori infection. World J Gastroenterol. 11, 6134-43 (2005).
36. Tegtmeyer, N. et al. Role of the cag-pathogenicity island encoded type IV secretion system in Helicobacter pylori pathogenesis. FEBS J. 278, 1190-202 (2011). Review.
37. Cendron, L. & Zanotti, G. Structural and functional aspects of unique type IV secretory components in the Helicobacter pylori cag-pathogenicity island. FEBS J. 278, 1223-31 (2011).
38. Poursina, F. et al. Assessment of cagE and babA mRNA expression during morphological conversion of Helicobacter pylori from spiral to coccoid. Curr. Microbiol. 66, 406-13 (2012).
39. Itoh, H. et al. Mammalian HSP60 is a major target for an immunosuppressant mizoribine. J. Biol. Chem. 274, 35147-35151 (1999).
40. Miyazaki, T. et al. 73-kDa molecular chaperone HSP73 is a direct target of antibiotic gentamicin. J. Biol. Chem. 279, 17295-17300 (2004).
41. Yamaguchi, H. Colony formation by Helicobacter pylori after long-term incubation under anaerobic conditions. FEMS Microbiol. Lett. 175, 107-111 (1999).